- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04536701
- Original Trial
Learning and Improving Alzheimer's Patient-Caregiver Relationships Via Smart Healthcare Technology
Collaborative Research: Learning and Improving Alzheimer's Patient-Caregiver Relationships Via Smart Healthcare Technology
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria for persons with dementia:
- Females and males
- Age 60-90 years
- Physician documentation of dementia: Alzheimer's disease, vascular, mixed or unspecified type
- Community-dwelling (living in the home)
- Fluent in English
Inclusion criteria for family caregivers:
- Age 21 years or older
- Informal, unpaid caregiver who resides with the care recipient
- Fluent in English
- Functioning home Wifi
- Scoring above a 3 on the Revised Memory and Behavior Problems Checklist, a clinical cut-off point used to determine caregiver stress.
Exclusion Criteria for persons with dementia:
- Presence of acute illness as this could lead to delirium
- Alcohol abuse or dependence within the past 2 years (DSM-IV criteria)
- History of significant psychiatric illness (e.g., schizophrenia).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Dementia/Caregiver Dyad
All dementia/caregiver dyads will have in-home acoustic monitoring to classify mood and will be provided mindfulness-based stress reduction recommendations via a smart phone.
|
The purpose of this project is to develop a monitoring, modeling, and interactive recommendation solution (for caregivers) for in-home dementia patient care that focuses on caregiver-patient relationships.
This includes monitoring for mood and stress and analyzing the significance of monitoring those attributes to dementia patient care and subsequent behavior dynamics between the patient and caregiver.
In addition, novel and adaptive behavioral suggestions will be provided to family caregivers via text messages on project Smart phones at the right moments aimed to help improve familial interactions related to caregiving, which over time should ameliorate the stressful effects of the patient's illness and reduce strain on caregivers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Caregiver Strain
Time Frame: Baseline, 4 months
|
Modified Caregiver Strain Index (MCSI): It is a 13-item self-report measure that examines both subjective and objective elements of caregiver strain.
The MCSI showed excellent inter-item and test-retest reliability and was correlated in expected directions with relevant criteria [32].
It has excellent reliability and validity, displays adequate clinical sensitivity, has an established cut-off for determining functional/dysfunctional systems, and has been used successfully on a variety of mental health outcomes [28].
We will use a practice tracking worksheet to assess how much the caregivers practice the exercises over the course of the study.
Minimum score: 0; Maximum score: 26.
High scores indicates higher caregiver strain.
|
Baseline, 4 months
|
|
Depression Anxiety Stress Scale (DASS)
Time Frame: Baseline, 4 months
|
The DASS is a set of three self-report scales designed to measure the negative emotional states of depression, anxiety and stress in 3 subscales of 14 items each. The scores of each subscale range from 0-42. These subscales are scored by the addition of the total item scores. Total score is obtained by summing all subscores. Total minimum score: 0; Total maximum score: 126; A higher score indicates higher levels of emotional distress, depression, anxiety and stress. Total: Normal - 0-32; Mild - 33-39; Moderate - 40-49; Severe - 50-57; Extremely severe - 58+ Depression: Normal - 0-9; Mild -10-12; Moderate -13-20; Severe - 21-27; Extremely severe - 28-42 Anxiety: Normal - 0-6; Mild - 7-9; Moderate -10-14; Severe -15-19; Extremely severe - 20-42 Stress: Normal - 0-10; Mild - 11-18; Moderate -19-26; Severe - 27-34; Extremely severe - 35-42 |
Baseline, 4 months
|
|
Revised Memory and Behavior Problems Checklist (RMBPC)
Time Frame: Baseline, 4 months
|
RMBPC 24-item, caregiver-report of observable behavioral problems in dementia patients AND the caregiver's stress reactions to these disturbances. It provides a total score and 3 subscale scores (memory, depression, and disruptive behaviors) and scores for caregiver reactions. Score ranges - Frequency: Total 0-96; Disruptive 0-32; Depressive 0-36; Memory 0-24. Sum items with scores of 0 to 4 on subscales and total. If question score is 9, exclude it from the sum and item count. Sum items for each subscale, compute the mean item score for each subscale by dividing by the number of items included in the sum. Score ranges - Reaction Total 1-96; Disruptive 1-36; Depressive 1-36; Memory 1-24. Include only items with frequency scores of 1 to 4 in the reaction scoring. Compute the mean reaction score by summing reaction scores of these items and then dividing by the number of items included in the sum. A higher score indicates worse outcomes. |
Baseline, 4 months
|
|
Change in Caregiver Emotional Reactivity
Time Frame: Baseline, 4 months
|
The 16-item, Difficulties in Emotion Regulation Scale (DERS-16) will be used to measure caregivers' ability to regulate emotions at baseline and end of study.
The scale used is the brief version of a theoretically-driven, valid, and reliable self-report tool used to measure difficulties with emotion regulation.
The brief version will be more easily administered with the study population and has been shown to be valid and reliable [41].
Minimum score: 16; Maximum score: 80.
A higher score indicates higher levels of caregiver emotional reactivity.
|
Baseline, 4 months
|
|
Five Facet Mindfulness Questionnaire
Time Frame: Baseline, 4 months
|
Five Facet Mindfulness Questionnaire 39-item to measure capacity for five different domains of mindfulness practice at baseline and end of study. The five facets include non-reactivity to the inner experience, non-judgment of the inner experience, acting with awareness, observing, and describing internal states. All items are scored with a scale of 1-5. Some items are marked to be reverse scored. All items are scored and summed then divided by the total in each category by the number of items in that category to get an average category score. Each category is summed to calculate the Total then divided by the number of items to get an average item score for each subscale. A higher score indicates higher levels of caregiver capacity for mindfulness practices and better outcomes. Score ranges: Total 1-5; Observing 1-5; Describing 1- 5; Acting with Awareness 1-5; Non-judging 1-5; Nonreactivity 1-5 |
Baseline, 4 months
|
|
Family Assessment Device (FAD)
Time Frame: Baseline, 4 months
|
The FAD is a self-report measure that is given as a set of seven subscales measuring a different dimension of family function. Scores for each dimension (problem solving, communication, roles, affective responsiveness, affective involvement, behavior control, and general functioning) are calculated separately as the mean of the items in that subscale. Scored by summing the endorsed responses (1-4) for each subscale (negatively worded statements are reversed) and dividing by the number of items in each scale. A higher score indicates greater levels of family functioning on all subscales Score Ranges: Total 1-4; Problem Solving 1-5; Communication 1-4; Roles 1-4; Affective Responsiveness 1-6; Affective Involvement 1-7; Behavior Control 1-4; General Functioning 1-4 |
Baseline, 4 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Karen M Rose, PhD, Ohio State University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019B0406
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer Disease
-
ProgenaBiomeWithdrawnAlzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3 | Alzheimer Disease 4 | Alzheimer Disease 7 | Alzheimer Disease 17 | Alzheimer Disease 5 | Alzheimer Disease 6 | Alzheimer Disease 8 | Alzheimer Disease 10 | Alzheimer... and other conditionsUnited States
-
Cognito Therapeutics, Inc.Active, not recruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditionsUnited States
-
Stanford UniversityNot yet recruitingMCI With Increased Risk for Alzheimer Disease | Alzheimer s DiseaseUnited States
-
University of California, Los AngelesRecruitingAlzheimer Disease | Dementia Alzheimer Type | Alzheimer&Amp;#39;s Disease (AD) | Alzheimer&Amp;Amp;#39;s Disease | Mild Alzheimer&Amp;Amp;#39;s Disease | Moderate Alzheimer&Amp;Amp;#39;s Disease | Alzheimer&Amp;#39;s DementiaUnited States
-
AphiosNot yet recruitingDementia | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3
-
Heinrich-Heine University, DuesseldorfNot yet recruitingEarly Onset Alzheimer Disease | Alzheimer Disease (AD)Germany
-
Johns Hopkins UniversityNational Institutes of Health (NIH)Not yet recruiting
-
Xuanwu Hospital, BeijingEnrolling by invitation
-
ChainGen Biopharma LtdChainGen Biopharma (Australia) Pty LtdNot yet recruiting
-
University Hospital, GrenobleRecruiting
Clinical Trials on Mood Monitoring and Behavioral Recommendation System
-
University of RochesterUniversity of South Florida; United States Department of Defense; University... and other collaboratorsRecruiting
-
Mental Health Services in the Capital Region, DenmarkMaria Faurholt-Jepsen, MD, DMSc; The Mental Health Services in the Capital...RecruitingBipolar DisorderDenmark
-
University of Alabama at BirminghamCompletedAlcohol Use | HIV PositiveUnited States
-
I.M. Sechenov First Moscow State Medical UniversityUnknownCognitive Dysfunction | Cerebral Small Vessel Diseases | Periodic Limb Movement DisorderRussian Federation
-
Ilona MyllyniemiUniversity of CambridgeNot yet recruitingTracking Mood: The Effects of Daily Mood Tracking VAS on Alcohol Consumption in Adult Heavy DrinkersAlcohol Drinking | Alcohol Dependence | Alcohol Use Disorder | Alcohol Abuse | Alcohol Intoxication
-
Montefiore Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); National Center for Advancing...CompletedStress, Psychological | Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis | Depression, AnxietyUnited States
-
Federal State Budgetary Institution, V. A. Almazov...RecruitingGestational Diabetes Mellitus (GDM)Russian Federation
-
Children's Hospital Medical Center, CincinnatiNational Institute of Mental Health (NIMH)CompletedAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Drexel UniversityCompletedObesity | OverweightUnited States
-
Arno Schmidt-TrucksässRecruitingDepression | Burnout | Stress Related DisorderSwitzerland